Appointments: Promethera, HealthTell, Baxter, Alzheon, Gilead, Arena and Ligand

Promethera Biosciences SA NV has appointed Henrik L. Luessen chief business officer (CBO), Nancy Veulemans vice president clinical & medical affairs and Decebal Bora vice president regulatory affairs. Luessen is the founder and managing director of Tytonis B.V and previously was CBO at OctoPlus NV. With more than 25 years' experience, Veulemans was senior advisor regulatory at Promethera and has worked at various biopharma companies including Bristol Myers Squibb International and Pfizer Inc. Bora joins Promethera from PTC Therapeutics Inc., where he was executive director regulatory affairs and has worked for several companies including Biogen Inc., F. Hoffmann-La Roche Ltd, Baxter World Trade Corp. and ActoGeniX NV.

Baxter International Inc. has named Stephen N. Oesterle to its board of directors. He previously was senior vice president,...